Cargando…
Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes
OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357213/ https://www.ncbi.nlm.nih.gov/pubmed/22474040 http://dx.doi.org/10.2337/dc11-2163 |
_version_ | 1782233637540855808 |
---|---|
author | Rausch, Joseph R. Hood, Korey K. Delamater, Alan Shroff Pendley, Jennifer Rohan, Jennifer M. Reeves, Grafton Dolan, Lawrence Drotar, Dennis |
author_facet | Rausch, Joseph R. Hood, Korey K. Delamater, Alan Shroff Pendley, Jennifer Rohan, Jennifer M. Reeves, Grafton Dolan, Lawrence Drotar, Dennis |
author_sort | Rausch, Joseph R. |
collection | PubMed |
description | OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9–11 years) to describe the mutual influences of glycemic control as measured by HbA(1c) and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. RESULTS: HbA(1c) increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA(1c). A change (increase) in HbA(1c) was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. CONCLUSIONS: The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence. |
format | Online Article Text |
id | pubmed-3357213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-33572132013-06-01 Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes Rausch, Joseph R. Hood, Korey K. Delamater, Alan Shroff Pendley, Jennifer Rohan, Jennifer M. Reeves, Grafton Dolan, Lawrence Drotar, Dennis Diabetes Care Original Research OBJECTIVE: To test models of unidirectional and bidirectional change between treatment adherence and glycemic control in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS: We conducted a 2-year longitudinal, multisite study of 225 youth with type 1 diabetes recruited at the cusp of adolescence (aged 9–11 years) to describe the mutual influences of glycemic control as measured by HbA(1c) and treatment adherence as measured by blood glucose monitoring frequency (BGMF) during the transition to adolescence. RESULTS: HbA(1c) increased from 8.2 to 8.6% (P < 0.001) and BGMF decreased from 4.9 to 4.5 checks per day (P < 0.02) during the 2-year period. Changes in the BGMF slope predicted changes in HbA(1c). A change (increase) in HbA(1c) was associated with a change (decrease) in BGMF of 1.26 (P < 0.001) after controlling for covariates. CONCLUSIONS: The magnitude of the effect of declining treatment adherence (BGMF) on glycemic control in young adolescents may be even greater than declines observed among older adolescents. BGMF offers a powerful tool for targeted management of glycemic control for type 1 diabetes during the critical transition to adolescence. American Diabetes Association 2012-06 2012-05-11 /pmc/articles/PMC3357213/ /pubmed/22474040 http://dx.doi.org/10.2337/dc11-2163 Text en © 2012 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
spellingShingle | Original Research Rausch, Joseph R. Hood, Korey K. Delamater, Alan Shroff Pendley, Jennifer Rohan, Jennifer M. Reeves, Grafton Dolan, Lawrence Drotar, Dennis Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title | Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title_full | Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title_fullStr | Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title_full_unstemmed | Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title_short | Changes in Treatment Adherence and Glycemic Control During the Transition to Adolescence in Type 1 Diabetes |
title_sort | changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357213/ https://www.ncbi.nlm.nih.gov/pubmed/22474040 http://dx.doi.org/10.2337/dc11-2163 |
work_keys_str_mv | AT rauschjosephr changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT hoodkoreyk changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT delamateralan changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT shroffpendleyjennifer changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT rohanjenniferm changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT reevesgrafton changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT dolanlawrence changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes AT drotardennis changesintreatmentadherenceandglycemiccontrolduringthetransitiontoadolescenceintype1diabetes |